Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Norming

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Urology|March 1, 1996
Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized populationO Gustafsson, U Norming, S Gustafsson, et al.
Scandinavian Journal of Urology and Nephrology|January 30, 1999
Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer--a study of a randomly selected population of 2,400 menO Gustafsson, E Mansour, U Norming, et al.
The Journal of Urology|January 1, 1992
Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesionsU Norming, B Tribukait, H Gustafson, et al.
Urology|May 1, 1999
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mLM Törnblom, U Norming, J Adolfsson, et al.
The Journal of Urology|December 1, 1992
Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 menO Gustafsson, U Norming, L E Almgård, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Digital rectal examination versus transrectal ultrasound in detection of prostate cancer. Preliminary results from a study of a randomly selected populationU Norming, O Gustafsson, C R Nyman, et al.
Journal of Internal Medicine|December 9, 2010
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screeningA Kjellman, O Akre, O Gustafsson, et al.
BJU International|June 20, 2001
The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reactionT Wada, J Louhelainen, K Hemminki, et al.
Lakartidningen|May 6, 1992
[A study on prostatic cancer. The patient can decide himself: medical or surgical treatment]K Wijma, E Varenhorst, H Hjertberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and gradeT Wada, J Louhelainen, K Hemminki, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Urology|March 1, 1996
Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized populationO Gustafsson, U Norming, S Gustafsson, et al.
Scandinavian Journal of Urology and Nephrology|January 30, 1999
Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer--a study of a randomly selected population of 2,400 menO Gustafsson, E Mansour, U Norming, et al.
The Journal of Urology|January 1, 1992
Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesionsU Norming, B Tribukait, H Gustafson, et al.
Urology|May 1, 1999
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mLM Törnblom, U Norming, J Adolfsson, et al.
The Journal of Urology|December 1, 1992
Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 menO Gustafsson, U Norming, L E Almgård, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Digital rectal examination versus transrectal ultrasound in detection of prostate cancer. Preliminary results from a study of a randomly selected populationU Norming, O Gustafsson, C R Nyman, et al.
Journal of Internal Medicine|December 9, 2010
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screeningA Kjellman, O Akre, O Gustafsson, et al.
BJU International|June 20, 2001
The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reactionT Wada, J Louhelainen, K Hemminki, et al.
Lakartidningen|May 6, 1992
[A study on prostatic cancer. The patient can decide himself: medical or surgical treatment]K Wijma, E Varenhorst, H Hjertberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and gradeT Wada, J Louhelainen, K Hemminki, et al.
Pageof 4